We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.
Add this topic to your myFT Digest for news straight to your inbox
The investing framework is now facing a mountain of troubles, almost all of them of its own making
Value investors and those bullish on growth companies need to look at what they have in common
And the ESG gravy train
Assumptions about valuations and economic indicators have more power than they should
If an employee is paid with options or restricted stock, it will hit your share’s value
US group hopes to buy Irish drugmaker for more than $380 per share
UK Edition
